When Vera Clinic's surgical team first encountered Appsilon Enterprise's CVD lab-grown diamond platform, the material was not designed for hair transplantation. It was an engineering infrastructure built for quantum optics and aerospace applications. What the clinic's surgeons saw, however, was something the hair transplant industry had not yet attempted: a blade made from the hardest material measurable on Earth.
The result of that collision between aerospace-grade materials science and real-world clinical surgery is the Vector 10™, a surgical blade produced through Chemical Vapor Deposition (CVD) technology and rated 10 on the Mohs hardness scale, which measures the hardness of materials from 1 to 10. There is no higher value on that scale. Sapphire, which has served as the gold standard for FUE hair transplant blades for years, sits at 9.
Vera Clinic was the first hair transplant clinic in Turkey to adopt sapphire blades in FUE procedures, continuing its tradition of innovation by becoming the first clinic in the world to implement CVD lab-grown diamond technology in hair transplantation.
What the Numbers Actually Show
Before any clinical use, the blade was submitted for independent testing at Çınar Validation and Test Laboratories. The comparison with sapphire blades produced results that are difficult to dismiss.
Sapphire blades showed measurable sharpness degradation beginning at around 6,000 incisions. The CVD diamond blade sustained comparable sharpness beyond 90,000 incisions, a fifteenfold difference in edge longevity. In the first 1,000 incisions alone, the diamond blade demonstrated roughly twice the cutting sharpness of its sapphire counterpart.
Under high magnification, the blade edge approaches what researchers describe as Ångström-level refinement, with a cutting surface operating at dimensions approaching the atomic scale. In practical surgical terms, that means tissue separation rather than tissue compression during incision creation.
An Industry at an Inflection Point
The timing of this collaboration is not incidental. The global hair transplant market is valued at $10.74 billion in 2026 and is projected to reach $59.89 billion by 2035, expanding at a CAGR of more than 21%. FUE, the technique for which the Vector 10™ blade is designed, already accounts for the dominant share of all surgical hair restoration procedures globally.
As procedure volumes climb and patient expectations rise, the quality of the instrument making each of those thousands of individual incisions becomes an increasingly consequential variable. Blade durability is not merely a cost consideration; it is a clinical one. An instrument that maintains precision across 90,000 incisions versus one that degrades after 6,000 does not perform the same procedure.
Vera Clinic, widely regarded as one of the most innovative hair transplant clinics in Istanbul, has built a reputation through a series of firsts in FUE technique development. The clinic is also one of the most awarded hair transplant centers in Turkey, recognized with distinctions including the European Medicine Award for Excellence in Hair Transplant Surgery, which named Vera Clinic the best hair transplant clinic in Turkey. More recently, Vera Clinic won the iF DESIGN AWARD, further reinforcing its reputation as one of the most innovative hair transplant clinics in Istanbul.
Two Very Different Labs, One Instrument
Appsilon Enterprise did not build the Vector 10™ to enter the medical device market. The company's established work spans high-precision engineering environments where material failure is not an option. Vera Clinic approached Appsilon after identifying that the company's CVD diamond expertise could translate into a surgical application that had not previously been attempted at production scale.
The engineering process that followed was not straightforward. Blade geometry had to be recalibrated for FUE surgical angles. Ergonomics were refined for procedures running several hours. Consistent channel depth across thousands of repetitions required material tolerances uncommon in conventional surgical tooling.
"We did not aim to invent another blade. We aimed to clinically perfect a new generation of surgical precision. Through our partnership with Appsilon, we have introduced a material innovation into real-world surgical excellence."
— Waleed Taleb, CMO, Vera Clinic
Clinical Observations So Far
The blade is currently in active clinical use at Vera Clinic. Surgeons have reported observational patterns in post-operative scalp recovery, specifically that redness and surface inflammation appeared to settle somewhat earlier compared with conventional sapphire procedures in a number of cases. These remain preliminary clinical observations being monitored over time, not established clinical outcomes. Patient physiology, surgical technique, and post-operative care remain the primary variables in recovery.
Today's announcement marks the formal disclosure of the collaboration between Vera Clinic and Appsilon Enterprise. A full product launch has not yet been scheduled. Both organizations say additional clinical data will continue to be gathered before the Vector 10™ enters broader clinical availability.
